Filana Therapeutics, Inc. (FLNA): Total Liabilities
$43.95M
As of 2025-12-31
$40.23M
As of 2026-03-31
+82.0%
3-year compound annual growth
+83.7%
5-year compound annual growth
+32.9%
10-year compound annual growth
| Period ended | Total Liabilities | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $43.95M | +271.6% | 2026-03-12, Balance as of period end |
| 2024-12-31 | $11.83M | -16.7% | 2026-03-12, Balance as of period end |
| 2023-12-31 | $14.20M | +94.6% | 2025-03-03, Balance as of period end |
| 2022-12-31 | $7.29M | -43.3% | 2024-02-28, Balance as of period end |
| 2021-12-31 | $12.87M | +512.7% | 2023-02-28, Balance as of period end |
| 2020-12-31 | $2.10M | +51.4% | 2022-03-01, Balance as of period end |
| 2019-12-31 | $1.39M | +171.4% | 2021-03-23, Balance as of period end |
| 2018-12-31 | $511.0K | -54.9% | 2020-03-26, Balance as of period end |
| 2017-12-31 | $1.13M | +70.2% | 2019-03-29, Balance as of period end |
| 2016-12-31 | $665.0K | -73.9% | 2018-02-06, Balance as of period end |
| 2015-12-31 | $2.55M | +200.1% | 2017-03-07, Balance as of period end |
| 2014-12-31 | $850.0K | -52.8% | 2016-03-03, Balance as of period end |
| 2013-12-31 | $1.80M | -95.9% | 2015-02-18, Balance as of period end |
| 2012-12-31 | $43.72M | -19.9% | 2014-02-05, Balance as of period end |
| 2011-12-31 | $54.57M | -17.6% | 2013-02-08, Balance as of period end |
| 2010-12-31 | $66.26M | n/a | 2012-02-09, Balance as of period end |
Total Liabilities at similar companies
| Company | Year ended | Total Liabilities | Change YoY |
|---|---|---|---|
| Filana Therapeutics, Inc. (FLNA) | 2025-12-31 | $43.95M | +271.6% |
| Camp4 Therapeutics Corp (CAMP) | 2025-12-31 | $70.10M | +362.3% |
| Aardvark Therapeutics, Inc. (AARD) | 2025-12-31 | $10.55M | +95.6% |
| Kyntra Bio, Inc. (KYNB) | 2025-12-31 | $115.12M | -71.1% |
| PMV Pharmaceuticals, Inc. (PMVP) | 2025-12-31 | $11.85M | -22.1% |
| Avalo Therapeutics, Inc. (AVTX) | 2025-12-31 | $33.41M | +88.8% |
| Rafael Holdings, Inc. (RFL) | 2025-07-31 | $15.74M | +48.8% |
| Milestone Pharmaceuticals Inc. (MIST) | 2025-12-31 | $71.79M | +15.1% |
| Korro Bio, Inc. (KRRO) | 2025-12-31 | $62.07M | -5.7% |
Compare FLNA, CAMP, AARD, KYNB side by side · Screen every company in Pharmaceutical Preparations ↗